Background: The relative contribution and interaction of risk factors for multiple sclerosis (MS) have not been evaluated.
Objectives: To determine whether vitamin D status is associated with antibody levels to common viruses in pediatric-onset MS or clinically isolated syndrome (CIS) patients and controls.
Methods: We assessed whether vitamin D status was associated with viral antibody levels to Epstein–Barr virus, cytomegalovirus (CMV), and herpes simplex virus (HSV)-1 or -2 in subjects who demonstrated evidence of remote infection with these viruses and whether these associations differed depending on disease status.
Results: In 140 subjects, vitamin D status was weakly associated with antibody levels to CMV but not to the other viruses. However, there were some interactions between vitamin D status and disease state. Among those with vitamin D sufficiency (≥30 ng/ml), MS/CIS patients had higher antibody levels to Epstein–Barr nuclear antigen-1 than controls. Vitamin D sufficiency was associated with higher CMV antibody levels in MS/CIS subjects but lower CMV antibody levels in controls. Higher vitamin D levels appeared to be associated with higher titers to HSV-2 in MS/CIS patients but not controls.
Conclusions: Vitamin D status may be differentially associated with antibody levels to common childhood viruses among seropositive subjects.
MungerKLLevinLIHollisBWHowardNSAscherioA. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA2006; 296: 2832–2838.
2.
BarcellosLFSawcerSRamsayPP. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet2006; 15: 2813–2824.
3.
HernanMAOlekMJAscherioA. Cigarette smoking and incidence of multiple sclerosis. Am J Epi2001; 154: 69–74.
4.
LevinLIMungerKLRubertoneMV. Temporal relationship between elevation of Epstein–Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA2005; 293: 2496–2500.
5.
DiPauliFReindlMEhlingR. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Mult Scler2008; 14: 1026–1030.
6.
HolmoyT. Vitamin D status modulates the immune response to Epstein Barr virus: synergistic effect of risk factors in multiple sclerosis. Med Hypotheses2008; 70: 66–69.
7.
SabettaJRDePetrilloPCiprianiRJSmardinJBurnsLALandryML. Serum 25-hydroxyvitamin D and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One2010; 14: e11088–e11088.
8.
MehtaSGiovannucciEMugusiFM. Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS One2010; 5: e8770–e8770.
9.
LunemannJDTintoreMMessmerB. Elevated Epstein–Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann Neurol2010; 67: 159–169.
10.
JamesJANeasBRMoserKL. Systemic lupus erythematosus in adults is associated with previous Epstein–Barr virus exposure. Arthritis Rheum2001; 44: 1122–1126.
11.
MowryEMKruppLBMilazzoM. Vitamin D status is associated with subsequent relapse rate in pediatric-onset multiple sclerosis. Ann Neurol2010; 67: 618–624.
12.
RamagopalanSVMaugeriNJHandunnetthiL. Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet2009; 5: e1000369–e1000369.
13.
FarrellRAAntonyDWallGR. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology2009; 73: 32–38.
